These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28413148)

  • 1. Incorporating Site-less Clinical Trials Into Drug Development: A Framework for Action.
    Hirsch IB; Martinez J; Dorsey ER; Finken G; Fleming A; Gropp C; Home P; Kaufer DI; Papapetropoulos S
    Clin Ther; 2017 May; 39(5):1064-1076. PubMed ID: 28413148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
    Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
    Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials integrity: a CRO perspective.
    Beach JE
    Account Res; 2001; 8(3):245-60. PubMed ID: 12481762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Wearable, Mobile, and Sensor Technology in Cancer Clinical Trials.
    Cox SM; Lane A; Volchenboum SL
    JCO Clin Cancer Inform; 2018 Dec; 2():1-11. PubMed ID: 30652590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current practice and perspectives in CRO oversight based on a survey performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa).
    Hennig M; Hundt F; Busta S; Mikus S; Sanden PH; Sörgel A; Ruppert T
    Ger Med Sci; 2017; 15():Doc02. PubMed ID: 28163667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO model.
    Goldenberg NA; Spyropoulos AC; Halperin JL; Kessler CM; Schulman S; Turpie AG; Skene AM; Cutler NR; Hiatt WR;
    Blood; 2011 Feb; 117(7):2089-92. PubMed ID: 21068436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive care telemedicine: evaluating a model for proactive remote monitoring and intervention in the critical care setting.
    Groves RH; Holcomb BW; Smith ML
    Stud Health Technol Inform; 2008; 131():131-46. PubMed ID: 18305328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRAFT-A Proposed Framework for Decentralized Clinical Trials Participation in Canada.
    Sundquist S; Batist G; Brodeur-Robb K; Dyck K; Eigl BJ; Lee DK; Limoges J; Longstaff H; Pankovich J; Sadura A; Sullivan P; Dancey JE
    Curr Oncol; 2021 Sep; 28(5):3857-3865. PubMed ID: 34677247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative and cost effectiveness of telemedicine versus telephone counseling for smoking cessation.
    Richter KP; Shireman TI; Ellerbeck EF; Cupertino AP; Catley D; Cox LS; Preacher KJ; Spaulding R; Mussulman LM; Nazir N; Hunt JJ; Lambart L
    J Med Internet Res; 2015 May; 17(5):e113. PubMed ID: 25956257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk-Based Monitoring: Key Conditions in Collaboration Between Contract Research Organization and Sponsor.
    Wolfs M; Bambic A; Lange BS; Galante K; Plaza RS; O'Conallain C; Racaro G; Giblin M; Djali S
    Ther Innov Regul Sci; 2019 Jul; 53(4):512-518. PubMed ID: 30157695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacovigilance during the pre-approval phases: an evolving pharmaceutical industry model in response to ICH E2E, CIOMS VI, FDA and EMEA/CHMP risk-management guidelines.
    Hartford CG; Petchel KS; Mickail H; Perez-Gutthann S; McHale M; Grana JM; Marquez P
    Drug Saf; 2006; 29(8):657-73. PubMed ID: 16872240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Future of Contract Research Organizations in Dermatology and Aesthetic Research.
    Nestor M; Pariser D; Del Rosso J; Glaser DA; Goldberg D; Ablon G; Lorenc ZP; Santos J
    J Clin Aesthet Dermatol; 2022 Sep; 15(9):16-19. PubMed ID: 36213607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Future of Contract Research Organizations in Dermatology and Aesthetic Research.
    Nestor M; Pariser D; Del Rosso J; Glaser DA; Goldberg D; Ablon G; Lorenc ZP; Santos J
    J Clin Aesthet Dermatol; 2022 Dec; 15(12 Suppl 1):S28-S31. PubMed ID: 36588785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Legal and ethical obligations to conduct a clinical drug trial in Australia as an investigator initiated and sponsored study for an overseas pharmaceutical company.
    Beran RG
    Med Law; 2004; 23(4):913-24. PubMed ID: 15685926
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.